Comparison Chart Cleo Diagnostics Ltd

Equities

Market Closed - Australian S.E. Other stock markets 01:03:11 2024-07-01 EDT			5-day change	1st Jan Change
0.37 ^AUD	+8.82%		+15.62%	+111.43%

06-26	Cleo Diagnostics Secures US FDA Feedback for Ovarian Cancer Test	MT
06-23	7,500,000 Ordinary Shares of Cleo Diagnostics Ltd are subject to a Lock-Up Agreement Ending on 23-JUN-2024.	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	CLEO DIAGNOSTICS LTD	Diagnostic & Testing Substances	+8.82%	+15.62%	+111.43%	-	-	29.15M